Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Hematology  |  Immunology  |  Oncology

Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Lymphoma Clinical Trials

A listing of Lymphoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found (47) clinical trials

The GD-2008 ALL Protocol for Childhood Acute Lymphoblastic Leukemia

The modification includes: In the induction phase, the agent of dexamethasone 6 mg/m2 is used instead of prednisone after prednisone prophase. The phase "CAM" is 2 weeks for SR patients and 4 weeks for IR and HR patients,respectively. Both the SR and IR treatments involve the protocol mM /M (8 …

Phase

A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy

Peripheral T-cell lymphomas (PTCL) are a group of aggressive and diverse lymphoproliferative disorders. It is characterized by the presence of malignant mature T-cells or NK cells. There is as yet no consensus regarding standard frontline or relapsed/refractory therapy for PTCL. A previous phase II study conducted in US showed durable …

Phase

Treatment of Diffuse Large B Cell Lymphoma

The purpose of this study is to evaluate the efficacy and safety of Yangzhengxiaoji Capsule Combination Chemotherapy for III/IV Diffuse Large B Cell Lymphoma.

Phase

Study of Standard and Individualized Treatment Model for Relapse and Refractory Lymphatic System Malignant Tumors

The purpose of the study is to research the standard and individualized treatment model for relapse and refractory lymphatic system malignant tumors.

Phase

The Comparison of RCD Versus BCD in Newly Diagnosed Waldenstr m Macroglobulinemia

Newly diagnosed WM patients will be randomly assigned to BCD or RCD group for introduction chemotherapy. Chemotherapeutic response will be evaluated after 3 cycles. If a PR or better response achieves, addition 3 cycles will be given. If not, patients will be crossed to control group for another 3 cycles. …

Phase

Comparison of Methotrexate Versus Interferon-alfa 2b in Patients With Primary Cutaneous T-cell Lymphomas

Methotrexate and interferon are widely used drugs in treatment in patients with cutaneous T-cell Lymphomas. Efficacy and safety of both drugs have never been compared directly in one study. Patients will be randomly assigned to receive Methotrexate or Interferon Alfa 2b. Treatment will continue until disease progression or the development …

Phase

Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation

Lymphoma patients with anemia on day +15 post-transplant will be randomized to erythropoietin group or control group. Potential benefit of erythropoietin will be evaluatedon day +60 post-transplant.

Phase

Treatment of Primary CNS Lymphoma

Primary CNS lymphoma (PCNSL) is a rare B-cell variant of non-Hodgkin lymphoma that is confined to the brain, leptomeninges, spinal cord, and eyes. The optimum treatment for patients with PCNSL remains challenging and at present there is no universally accepted therapeutic approach for patients with newly diagnosed disease. The purpose …

Phase

The Efficacy of TCD Following by TP Maintenance Therapy in Newly Diagnosed WM

Enrolled patients will accept maximum 8 cycles of thalidomide plus cyclophosphamide and dexamethasone. if a partial remission response or better is achieved, thalidomide plus prednisone maintenance therapy will be given for no more than two years.

Phase

Comparison of ASCT and Conventional Chemotherapy in High Risk Waldenstr m Macroglobulinemia

WM patients with partial response after introduction chemotherapy will be recommended to adopt autologous stem cell transplantation or receive conventional chemotherapy (dependent on patient's choices). After transplantation or conventional chemotherapy, maintenance therapy with rituximab or thalidomide plus prednisone will be given for less than two years.

Phase